Reserved

CurrencyCurrent through May 31, 2023
Citation 21 C.F.R. §610.11a
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
1 firm's commentaries
  • FDA Proposes Removal Of Duplicative Biologics Requirements In Regulations
    • United States
    • Mondaq United States
    • September 2, 2014
    ...purity, and potency of licensed biologics. Specifically, the proposed change would remove the requirements contained in 21 C.F.R. §§ 610.11, 610.11a, and 680.3(b) from the regulations. Comments due November 20, The content of this article is intended to provide a general guide to the subjec......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT